In this study, we conducted combined intervention of IL-10 and IGF-1 in NOD mice with diabetes at onset stage and evaluated its protective effects on the residual islet β- cells, hoping to provide a theoretical basis for early clinical treatment of T1D. This evidence concerns the gene IL10 and diabetes mellitus.